Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SHANGHAI PECHEM
00338
| (FY)Nov 30, 2025 | (Q4)Nov 30, 2025 | (Q3)Aug 31, 2025 | (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 39.15%-393.08K | 90.84%-10.04K | 87.83%-19.44K | 92.11%-23.94K | -365.00%-339.65K | -46.65%-646.02K | -383.63%-109.62K | 21.56%-159.79K | -22.12%-303.57K | -171.96%-73.04K |
| Net income from continuing operations | 32.54%-563.57K | 48.49%-178.08K | 81.79%-28.75K | 59.39%-83.58K | -116.76%-273.16K | 56.90%-835.46K | -273.95%-345.73K | 90.25%-157.89K | -88.67%-205.82K | -6.99%-126.02K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | -130.81%-22.83K | -25.94%-30.63K | ---- | ---- | ---- |
| Depreciation and amortization | -29.91%300 | -28.97%76 | -30.84%74 | -29.91%75 | -29.91%75 | 100.00%428 | 0.00%107 | 0.00%107 | --107 | --107 |
| Asset impairment expenditure | -82.29%22.76K | ---- | ---- | ---- | ---- | -91.42%128.5K | --128.5K | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | --0 | ---- | ---- | ---- | ---- | ---9.02K | ---- | ---- | ---- | --0 |
| Other non cashItems | 313.32%61.14K | 363.66%35.47K | 172.81%11.01K | --9.24K | --5.43K | --14.79K | --7.65K | --4.04K | ---- | ---- |
| Change In working capital | 11.26%86.29K | -21.34%109.74K | 87.18%-1.78K | 149.84%50.32K | -236.18%-72K | 205.24%77.56K | -10.18%139.51K | 83.11%-13.85K | 39.15%-100.96K | 179.34%52.87K |
| -Change in receivables | -58.00%-38.45K | 84.04%-761 | 59.88%-2.64K | 32.46%-6.48K | -738.31%-28.58K | -661.13%-24.34K | -159.76%-4.77K | -285.26%-6.57K | -1,431.63%-9.59K | 48.06%-3.41K |
| -Change in prepaid assets | 214.21%29.83K | 126.87%6.52K | --0 | -433.92%-4.02K | 9,655.24%27.33K | -616.66%-26.12K | -252.07%-24.25K | 82.36%-2.78K | 124.18%1.2K | -124.70%-286 |
| -Change in payables and accrued expense | -25.85%94.92K | -38.30%103.98K | 119.15%861 | 165.69%60.82K | -225.08%-70.75K | 272.08%128.01K | 28.26%168.53K | 93.56%-4.5K | 42.26%-92.58K | 132.47%56.56K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 39.15%-393.08K | 90.84%-10.04K | 87.83%-19.44K | 92.11%-23.94K | -365.00%-339.65K | -46.65%-646.02K | -383.63%-109.62K | 21.56%-159.79K | -22.12%-303.57K | -171.96%-73.04K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -5,880.40%-104.66K | -1,649.20%-8.75K | -47.5K | -46.96K | -16.00%-1.45K | 98.44%-1.75K | 96.15%-500 | 0 | 0 | 94.35%-1.25K |
| Capital expenditure reported | -5,763.89%-102.62K | -1,241.40%-6.71K | ---- | ---- | -16.00%-1.45K | 98.94%-1.75K | 96.15%-500 | --0 | --0 | 94.35%-1.25K |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net business purchase and sale | ---2.04K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -5,880.40%-104.66K | -1,649.20%-8.75K | ---47.5K | ---46.96K | -16.00%-1.45K | 98.44%-1.75K | 96.15%-500 | --0 | --0 | 94.35%-1.25K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -71.60%232.9K | 0 | -82.28%45K | 1.03%98K | -62.37%89.9K | 27.10%820.15K | 293.77%230.36K | 182.65%253.9K | -84.49%97K | 388.12%238.88K |
| Net issuance payments of debt | 300.22%184.9K | --0 | 12,361.58%45K | -48.45%50K | 276.97%89.9K | 139.42%46.2K | 100.31%367 | ---367 | 3,131.25%97K | -1,687.50%-50.8K |
| Net common stock issuance | -93.88%48K | --0 | --0 | --48K | --0 | -7.73%784.27K | --484.27K | --0 | --0 | --300K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | 88.21%-10.32K | -15,125.75%-254.27K | 2,599.95%254.27K | --0 | -122.56%-10.32K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -71.60%232.9K | --0 | -82.28%45K | 1.03%98K | -62.37%89.9K | 27.10%820.15K | 293.77%230.36K | 182.65%253.9K | -84.49%97K | 388.12%238.88K |
| Net cash flow | ||||||||||
| Beginning cash position | 184.17%265.98K | -86.32%19.93K | -18.88%41.88K | -94.28%14.78K | 184.17%265.98K | 7,509.67%93.6K | -21.99%145.73K | -83.96%51.62K | 21,669.65%258.19K | 7,509.67%93.6K |
| Current changes in cash | -253.63%-264.83K | -115.62%-18.79K | -123.32%-21.95K | 113.12%27.1K | -252.63%-251.2K | 86.62%172.38K | 228.99%120.25K | 169.72%94.11K | -164.43%-206.57K | 374,165.91%164.59K |
| End cash Position | -99.57%1.15K | -99.57%1.15K | -86.32%19.93K | -18.88%41.88K | -94.28%14.78K | 184.17%265.98K | 184.17%265.98K | -21.99%145.73K | -83.96%51.62K | 21,669.65%258.19K |
| Free cash from | 23.48%-495.7K | 84.79%-16.75K | 28.37%-115.36K | 92.56%-22.49K | -359.13%-341.1K | -6.63%-647.77K | -529.19%-110.12K | 28.36%-161.04K | 15.87%-302.32K | -51.67%-74.29K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.